GG
Gurer, Gulcan
10 yayın · 54 atıf · 2021–2026
Yayın
10
Atıf
54
Yıllar
5
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
Prevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database
|
2026 | Article | 0 |
|
The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry
|
2025 | Article | 2 |
|
Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar
|
2023 | Article | 10 |
|
Correlation of clinical signs and magnetic resonance imaging findings in patients with lumbar spondylosis
|
2023 | Article | 0 |
|
Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis
|
2022 | Article | 3 |
|
The clinical, functional, and radiological features of hand osteoarthritis: TLAR-osteoarthritis multi-center cohort study
|
2022 | Article | 4 |
|
Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry
|
2022 | Article | 3 |
|
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR
|
2021 | Article | 5 |
|
Familial Mediterranean fever: Health-related quality of life and associated variables in a national cohort
|
2021 | Article | 15 |
|
The impact of COVID-19 on familial Mediterranean fever: a nationwide study
|
2021 | Article | 12 |